论文部分内容阅读
目的：对血清hs-CRP水平在心力衰竭诊断及治疗中的临床价值进行研究，为心力衰竭的诊治和疗效提供参考。方法以我院2007年5月-2013年5月间心内科治疗的20例心力衰竭患者为观察组，选取同期心脏功能正常的患者20例为对照组。对其临床资料、治疗方法及治疗前后的血清hs-CRP水平进行组间比较及统计学分析。结果两组研究对象的基本临床资料差异无统计学意义（P＞0.05）；治疗前观察组研究对象的血清hs-CRP水平高于对照组，差异有统计学意义（P＜0.05）；治疗后观察组的血清hs-CRP水平较治疗前明显下降，且与对照组对比，差异无统计学意义（P＞0.05）。结论心力衰竭患者的血清hs-CRP水平在患病时发生显著变化，因此血清hs-CRP在心力衰竭的诊断和治疗效果评价中具有重要临床预测和治疗指导意义，可以在临床推广使用。“,”Objective To study the clinical value of serum hs-CRP levels in heart failure diagnosis and treatment, and provide reference for diagnosis and treatment of heart failure and the effect of. 20 cases of heart failure patients Methods in our hospital from 2007 May -2013 year in May the Department of Cardiology treatment as observation group, select the same period in patients with normal cardiac function of 20 patients in the control group. Comparison between groups and statistical analysis of serum hs-CRP level before and after the clinical data, treatment methods and treatment. Results there were no significant differences in basic clinical data of two groups (P > 0.05); serum hs-CRP levels prior to treatment group subjects than in the control group, the difference was statistical y significant (P 0.05). Serum hs-CRP levels in patients with heart failure significantly changed in the conclusion, the serum hs-CRP is of important clinical significance in evaluating the prognosis and treatment of the diagnosis and treatment of heart failure, can be used in clinical practice.